Collaborate with the clinical study teams to provide medical and scientific support for clinical sites
Key Opinion Leader (KOL) Engagement:
Develop and maintain strong relationships with clinical study investigators, key opinion leaders, and other external stakeholders in the field of dermatology
Act as a credible, scientific resource for KOLs, providing them with up-to-date and relevant information on Apogee's development programs
Stay abreast of the latest developments, publications, and research in dermatology to effectively communicate with experts in the field
Stay informed of competitor products and market trends in dermatology
Internal Collaboration
Work closely with cross-functional teams, including Medical Affairs, Clinical Development, Clinical Operations, and Business Development & Strategy to ensure strategic alignment
Provide insights and feedback to internal teams based on interactions with external stakeholders
Ideal Candidate
MSL : 2+ years relevant experience as outlined below
Advanced degree in a relevant medical or scientific field (MD/DO, PharmD, PhD, MS or equivalent)
Expertise in medical dermatology, specifically, atopic dermatitis preferred
Strong understanding of clinical study execution and appropriate interactions with clinical study sites
Knowledge of compliance requirements related to medical affairs activities and appropriate interactions with healthcare professionals
Knowledge of the dermatology therapeutic area and current treatment paradigms in inflammatory skin diseases
Excellent communication and presentation skills
Ability to build and maintain relationships with key opinion leaders and healthcare professionals
Successfully exhibit Apogee's C.O.R.E. values: Caring, Original, Resilient and Egoless
Position requires up to 75% travel across the territory, including mandatory attendance at All Hands meetings typically held twice per year, as well as regular travel to meet with clinical study site personnel and KOLs and to attend scientific conferences in the US and internationally, etc.
Candidate must reside in the territory
The anticipated salary range for candidates for this role is:
MSL: $210,000 - $230,000 per year
Sr. MSL: $230,000 - $250,000 per year
The final salary offered will depend on several factors, which may include, but is not limited to relevant years of experience, educational background, and geography.
Benefits
A great culture, grounded in our C.O.R.E. values: C aring, O riginal, R esilient and E golessOpportunity to work in a fast-paced, highly dynamic environment where you help shape the culture and company, wear multiple hats, and learn quicklyMarket competitive compensation and benefits package, including base salary, performance bonus, equity grant opportunities, health, welfare & retirement benefitsWe provide competitive time off, including three weeks PTO, two one-week company-wide shutdowns a yHealth insurancePaid time offEquity / stock optionsPerformance bonus
Additional Information
About Apogee Therapeutics
Founded in 2022, Apogee Therapeutics, Inc. (Ticker: APGE) is a well-funded, Nasdaq listed company that offers the opportunity to work in a fast-paced, highly dynamic environment. At Apogee, you can actively contribute to shaping the company culture, take on various roles and responsibilities, and grow professionally.
Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, Apogee's antibody programs are designed to overcome limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Zumilokibart (APG777), the company's most advanced program, is being initially developed for the treatment of atopic dermatitis (AD), which is the largest and one of the least penetrated I&I markets, as well as asthma. With four validated targets in its portfolio, Apogee is seeking to achieve best-in-class efficacy and dosing through monotherapies and combinations of its novel antibodies. Based on a broad pipeline and depth of leadership and expertise, the company believes it can deliver value and meaningful benefit to patients underserved by today's standard of care.
We are a fast-paced company committed to building an exceptional culture, founded on our C.O.R.E. values: C aring, O riginal, R esilient and E goless and a commitment to refusing to stop at "good enough".
If this sounds like you, keep reading!
Apogeetherapeutics · Worldwide